The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 06, 2018
Filed:
Apr. 10, 2015
National University Corporation University of Toyama, Toyama, JP;
Kracie Pharma, Ltd., Tokyo, JP;
National Cancer Center, Tokyo, JP;
Tokyo University of Science Foundation, Tokyo, JP;
Hiroyasu Esumi, Tokyo, JP;
Masafumi Ikeda, Chiba, JP;
Katsuya Tsuchihara, Chiba, JP;
Shigeki Chiba, Toyama, JP;
Satoshi Yomoda, Toyama, JP;
Takanori Kawashima, Toyama, JP;
Toshiki Okubo, Toyama, JP;
Yasuhiro Tezuka, Toyama, JP;
Kenta Murata, Toyama, JP;
National University Corporation University of Toyama, Toyama, JP;
Kracie Pharma, Ltd., Tokyo, JP;
National Cancer Center, Tokyo, JP;
Tokyo University of Science Foundation, Tokyo, JP;
Abstract
The purpose of the present invention is to provide an anticancer agent for potentiating an antitumor effect, alleviating side effects, and further extending the survival rate by concomitant use with a component having an anticancer effect. An anticancer agent combining arctigenin and a component other than arctigenin that has an anticancer effect, in which the anticancer agent may be a combination drug or may be a kit configured from a formulation containing arctigenin and a formulation containing a component that has an anticancer effect, and the concomitant use of arctigenin and the component having an anticancer effect more strongly inhibits tumor growth and reduces the proportion of cancer stem cells in the tumor, making it possible to extend the total survival time and to alleviate side effects caused by the component having an anticancer effect.